BD
ABOUT BD
PRODUCTS
Injection
Infusion
Anesthesia
Diabetes Care
Pharmaceutical Drug Delivery Systems
Disposal
Microbiology Solutions
Molecular Diagnostics
Women's Health & Cancer
Industrial Microbiology
Laboratory Automation
Diagnostic Systems Technical Service & Support
Sample Collection
Research Systems
Clinical Systems
Product Catalog
CAREERS
INVESTORS
NEWS
Worldwide
Locations
NORTH AMERICA
Canada (en)
Canada (fr)
United States
LATIN AMERICA
Argentina
Brazil
Chile
Colombia
Mexico
EUROPE
Belgium (nl)
Belgium (fr)
Denmark
Finland
France
Germany
Greece
Ireland
Italy
Netherlands
Norway
Spain
Sweden
Switzerland
United Kingdom
EASTERN EUROPE, MIDDLE EAST & AFRICA
Hungary (hu)
Hungary (en)
Russia
South Africa
ASIA PACIFIC
Australia/NZ
China
India
Japan
Korea
Philippines
Taiwan
Thailand
All other countries
BD Worldwide
>
Women's Health & Cancer
Women's Health & Cancer
Patients
Physicians
Labs
Cervical Cytology
Molecular Oncology
BD Affirm™ VPIII
Microbial
Identification Test
BD ProEx™ C
Reagent
Non-Gyn
Product Inserts
MSDS
Resources
Contact Us
Products Outside US
About Us
Products
Events
Contact Us
BD ProEx™ C Reagent
BD ProEx™ C ICC
|
BD ProEx™ C IHC
|
Aberrant S-Phase Induction
|
Slide Atlas
Publications
|
Other Products
|
Order
|
Reimbursement
|
FAQs
|
Events
Slide Atlas: Tissue
Control T1:
History of Squamous Cell Carcinoma. (50X)
Control T2:
History of CIN 3. (200X)
Cervical biopsy sample. Positive for Aberrant S-Phase Induction. Immunohistochemistry using BD SureDetect™ reagents.
Cervical biopsy sample. Positive for Aberrant S-Phase Induction. Immunohistochemistry using BD SureDetect™ reagents.